CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer

Published:2016-10-19 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Dai Meiou,Zhang Chenjing,Ali Ayad,Hong Xinyuan,Tian Jun,Lo Chieh,Fils-Aimé Nadège,Burgos Sergio A.,Ali Suhad,Lebrun Jean-Jacques

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep35383.pdf

Reference37 articles.

1. Magee, J. A., Piskounova, E. & Morrison, S. J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer cell 21, 283–296, doi: 10.1016/j.ccr.2012.03.003 (2012).

2. Visvader, J. E. & Lindeman, G. J. Cancer stem cells: current status and evolving complexities. Cell stem cell 10, 717–728, doi: 10.1016/j.stem.2012.05.007 (2012).

3. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105–111, doi: 10.1038/35102167 (2001).

4. Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nature reviews. Cancer 5, 275–284, doi: 10.1038/nrc1590 (2005).

5. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 100, 3983–3988, doi: 10.1073/pnas.0530291100 (2003).

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Slower CDK4 and faster CDK2 activation in the cell cycle;Structure;2024-08

2. Common skin cancers and their association with other non-cutaneous primary malignancies: a review of the literature;Medical Oncology;2024-05-17

3. Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy;npj Breast Cancer;2024-03-06

4. Transforming Growth Factor-β/Smad Signaling Inhibits Melanoma Cancer Stem Cell Self-Renewal, Tumor Formation and Metastasis;Cancers;2024-01-03

5. The clinical significance of the expression of PROM1/CD133, NOTCH2 and CDK4 in triple-negative breast cancer;2023-12-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3